OakChart

LifeStance Health Group Inc

LFSTHealthcare·Medical Care Facilities·USA·Mid·NASD·Nov 11 • 9:06 AM ET

14.77+0.21 (1.46%)
2026-11-11 15:08 CET
Market cap
5,535.58 USD m
Revenue, TTM
1,676.89 USD m
Net income, TTM
71.91 USD m
Free cash flow, TTM
179.27 USD m
EPS diluted, TTM
0.18
P/E
80.06
Compare

Price

LFST against its 20, 50 and 200-day averages
2050200beat
7.5010.0012.5015.0014.8M29.5MMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26LFSTclose 14.7720-day 13.2250-day 12.75200-day 9.6114.77

5.7% under 15.66 on 5 Nov 2026. Last 15 sessions, 28.7% high to low

Profile

LFST
52-week range, 91% of the way up
6.0115.66

Lifestance Health Group, Inc. provides outpatient mental health services. It offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy. The firm operates outpatient mental health platform as well as offers patients care virtually through its online delivery platform or in-person at its centers in 32 states. The company was founded by Michael K. Lester, Gwen H. Booth and Danish J. Qureshi in 2017 and is headquartered in Scottsdale, AZ.

IndexRUT
Employees10961
IPOJun 10, 2021
Beta1.29
ATR, 14d0.66
Rel volume0.00
Short float5.30%
Insider own32.13%
Inst own64.69%

Snapshot

6 groups

Valuation

IndexRUT
Market Cap5.62B
Enterprise Value5.87B
Income71.91M
Sales1.68B
Book/sh3.93
Cash/sh0.58
Dividend Est.-
Dividend TTM-
Dividend Ex-Date-
Dividend Gr. 3/5Y- -
Payout0.00%
Employees10961
IPOJun 10, 2021

Ratios

P/E80.06
Forward P/E61.63
PEG0.34
P/S3.35
P/B3.76
P/C25.67
P/FCF31.33
EV/EBITDA36.01
EV/Sales3.50
Quick Ratio1.44
Current Ratio1.44
Debt/Eq0.32
LT Debt/Eq0.28
Option/ShortYes / Yes

Earnings

EPS (ttm)0.18
EPS next Y0.24
EPS next Q0.05
EPS this Y860.33%
EPS next Y24.78%
EPS next 5Y182.11%
EPS past 3/5Y- -
Sales past 3/5Y18.33% 30.44%
EPS Y/Y TTM886.97%
Sales Y/Y TTM22.62%
EPS Q/Q1942.86%
Sales Q/Q25.30%
EarningsNov 05 BMO
EPS/Sales Surpr.62.60% 5.62%

Ownership

Insider Own32.13%
Insider Trans-35.99%
Inst Own64.69%
Inst Trans4.24%
ROA3.32%
ROE4.82%
ROIC3.77%
Gross Margin31.05%
Oper. Margin6.39%
Profit Margin4.29%
SMA2011.71%
SMA5015.87%
SMA20053.77%
Trades-

Technical

Shs Outstand380.19M
Shs Float258.02M
Short Float5.30%
Short Ratio2.72
Short Interest13.66M
52W High15.66 -5.67%
52W Low6.01 145.58%
Volatility9.46% 4.89%
ATR (14)0.66
RSI (14)69.56
Beta1.29
Rel Volume0.00
Avg Volume5.03M
Volume237

Performance

Perf Week3.95%
Perf Month19.90%
Perf Quarter20.88%
Perf Half Y82.37%
Perf YTD109.83%
Perf Year128.31%
Perf 3Y163.31%
Perf 5Y44.68%
Perf 10Y-
Recom1.45
Target Price16.30
Prev Close14.56
Price14.77
Change %1.46%

Analyst ratings

latest 10 of 20
DateActionAnalystRating changeTargetImplied
Jun 05, 2026InitiatedGGoldmanNeutral$9-39.1%
Dec 09, 2025InitiatedBBarclaysOverweight$8-45.8%
Nov 13, 2025InitiatedBBMO Capital MarketsOutperform$8-45.8%
Jul 25, 2025InitiatedBBTIG ResearchBuy$8-45.8%
May 27, 2025UpgradeUUBSNeutral → Buy$8.50-42.5%
Apr 08, 2025InitiatedKKeyBanc Capital MarketsOverweight$9-39.1%
Apr 03, 2025InitiatedCCanaccord GenuityBuy$8-45.8%
Dec 16, 2024UpgradeGGoldmanNeutral → Buy$10-32.3%
Jan 03, 2024InitiatedBBarclaysUnderweight$7-52.6%
May 15, 2023DowngradeTTD CowenOutperform → Market Perform$8 → $9-39.1%

Peers

Mkt cap
TickerCompanyMkt cap
ACHCAcadia Healthcare Company Inc3.59B
UHSUniversal Health Services Inc11.08B
CONConcentra Group Holdings Parent Inc5.38B
USPHU.S. Physical Therapy Inc1.48B
TDOCTeladoc Health Inc1.65B
MDPediatrix Medical Group Inc2.41B
PRVAPrivia Health Group Inc3.13B
ASTHAstrana Health Inc1.87B
CMPSCompass Pathways Plc ADR1.36B
HIMSHims & Hers Health Inc4.55B

Insider trading

latest 14 of 54
InsiderRelationshipDateTransactionCostSharesValueTotal heldForm
Burdick Kenneth ADirectorNov 10 '26Proposed Sale14.6075,0001,095,082Nov 10 12:04 PM
KIMBERLY PARDOINVESTORNov 10 '26Proposed Sale14.402,216,58531,918,824Nov 10 11:46 AM
RYAN PARDOOFFICERNov 10 '26Proposed Sale14.40587,9208,466,048Nov 10 09:45 AM
Burdick Kenneth ADirectorNov 09 '26Proposed Sale14.4166,589959,716Nov 09 02:47 PM
TPG GP A, LLC10% OwnerSep 11 '26Sale12.2918,409,705226,255,27479,691,702Sep 15 04:16 PM
Paunovich VukasinChief Technology OfficerSep 02 '26Sale12.8742,067541,402205,379Sep 04 04:51 PM
Paunovich VukasinOfficerSep 02 '26Proposed Sale12.8742,067541,245Sep 02 01:52 PM
DeLuca TeresaDirectorAug 14 '26Sale12.687,50095,10097,093Aug 18 05:13 PM
DeLuca TeresaDirectorAug 13 '26Sale12.2320,441249,993104,593Aug 14 05:48 PM
DeLuca TeresaDirectorAug 14 '26Proposed Sale12.687,50095,118Aug 14 03:45 PM
Burdick Kenneth ADirectorAug 11 '26Sale11.51500,0005,755,0002,970,810Aug 13 05:02 PM
DeLuca TeresaDirectorAug 13 '26Proposed Sale12.2320,441249,993Aug 13 11:29 AM
Paunovich VukasinChief Technology OfficerAug 10 '26Sale10.8544,394481,675247,446Aug 12 05:07 PM
TPG GP A, LLC10% OwnerAug 10 '26Sale10.6213,643,207144,890,85898,101,407Aug 12 05:02 PM

Held by

AUM
TickerCompanyAUM
IJRiShares Core S&P Small-Cap ETFAUM: 106.27B
IWMiShares Russell 2000 Index FundAUM: 77.38B
VTIVanguard Morningstar Total Stock Market ETFAUM: 687.42B
VBVanguard Morningstar Small-Cap ETFAUM: 79.59B
DFASU.S. Small Cap Portfolio-ETF Class Shares-
VBKVanguard Morningstar Small-Cap Growth ETFAUM: 22.34B
SPSMState Street SPDR Portfolio S&P 600TM Small Cap ETFAUM: 16.06B
VXFVanguard Extended Market Index ETFAUM: 30.47B
IWOiShares Russell 2000 Growth ETFAUM: 14.06B
XSMOInvesco S&P SmallCap Momentum ETFAUM: 2.74B

News

latest 14 of 206
  • LifeStance Health Group Announces Pricing of Secondary Public Offering (GlobeNewswire) +6.03%
  • LifeStance Health Group Announces Launch of Secondary Public Offering (GlobeNewswire)
  • LifeStance Beats And Raises Again, But A 2027 EHR Headwind And Price-Led Growth Test A Stock Priced At Its Highs (Earnings Whispers) -5.49%
  • Oscar Slips As LifeStance, HCA Climb On Earnings, Payment Hike (Investor's Business Daily)
  • LifeStance Health: Q3 Earnings Snapshot (Associated Press)
  • Loading…
  • LifeStance Reports Strong Third Quarter 2026 Financial Results and Raises Full Year Outlook (GlobeNewswire)
  • LifeStance Health Flirts With Latest Buy Point Despite Ongoing Stock Market Weakness (Investor's Business Daily)
  • LifeStance Patients With Treatment-Resistant Depression See Clinically Meaningful Improvement in Symptoms After Esketamine or TMS Treatment, New Data Shows (PR Newswire)
  • LifeStance Must Show Its Growth Surge Can Survive A Planned Margin Reinvestment (Earnings Whispers)
  • LifeStance to Host Third Quarter 2026 Earnings Conference Call on November 5, 2026 (GlobeNewswire) -5.09%
  • Nearly Half of Americans Say Fear of an Unwanted Viral Moment Keeps Them from Being Themselves in Public, LifeStance Survey Finds (PR Newswire)
  • These Two Healthcare Stocks Hit Key Milestones Today Why Is Wall Street Bullish On Them? (Stocktwits)
  • LifeStance Health Group Announces Pricing of Secondary Public Offering (GlobeNewswire)

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
2026Q32026-11-050.0600.0370.059455.86431.597
2026Q22026-08-060.0600.0330.061435.35414.586
2026Q12026-05-070.0400.0070.036403.5387.466
2025Q42026-02-250.010-0.0010.030382.2378.426
2025Q32025-11-060.000-0.0080.003363.8356.876
2025Q22025-08-07-0.010-0.024-0.010345.31345.257
2025Q12025-05-070.000-0.0310.002332.97332.917
2024Q42025-02-27-0.010-0.037-0.019325.5313.985
2024Q32024-11-07-0.020-0.068-0.016312.7302.256
2024Q22024-08-08-0.060-0.065-0.061312.33305.855
2024Q12024-05-09-0.060-0.079-0.056300.44299.026
2023Q42024-02-28-0.120-0.087-0.119280.6262.97
2023Q32023-11-08-0.170-0.068-0.165262.9255.186
2023Q22023-08-09-0.130-0.076-0.125259.58255.196
2023Q12023-05-10-0.090-0.092-0.095252.59246.695
2022Q42023-03-08-0.130-0.128-0.124229.4216.195

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
2021FY-1.050-0.870-1.050667.51668.47
2022FY-0.610-0.606-0.607859.5846.42
2023FY-0.510-0.484-0.5071,0561,038
2024FY-0.150-0.174-0.1521,2511,239
2025FY0.020-0.0040.0221,4241,420
2026FY-0.192--1,743
2027FY-0.240--1,981
2028FY-0.449--2,278

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
2026Q4S2026-11-06970452.66435465.64
2026Q4S2026-11-05960450.52435465.64
2026Q4S2026-10-27900438.56433.26446.46
2026Q4S2026-10-21920438.56433.26446.46
2026Q4S2026-10-20940438.56433.26446.46
2026Q4S2026-10-02990438.56433.26446.46
2026Q4S2026-10-01980438.1431.4446.46
2026Q4S2026-09-30980438.1431.4446.46
2026Q4S2026-09-11980438.1431.4446.46
2026Q4S2026-09-10980438.1431.4446.46
2026Q4S2026-08-18980438.1431.4446.46
2026Q4S2026-08-13980438.11431.4446.59
2026Q4S2026-08-07960436.1425446.59
2026Q4S2026-08-06940433.91425446.59

Estimate history

EPS, annual-0.158-0.833-1.05-0.607-0.507-0.1520.0250.1845
Period2019202020212022202320242025TTM
EPS, quarterly-0.016-0.0190.002-0.010.0030.030.0360.0610.057
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Sales, annual212.518377.217667.511859.5421055.6651250.971424.2851676.89
Period2019202020212022202320242025TTM
Sales, quarterly312.722325.48332.97345.311363.809382.195403.476435.354455.864
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Shares, annual373.649373.649374.255375.964378.725382.735388.318380.191
Period2019202020212022202320242025MRQ
Shares, quarterly382.64382.735388.826389.077389388.318387.813382.022380.191
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Income statement, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY
Total Revenue1,676.891,424.291,250.971,055.66859.54667.51377.22212.52
Cost of Goods Sold Incl. D&A1,156.161,017.94919.52834.01691.72520.14--
Gross Profit520.73406.35331.45221.66167.82147.37--
Selling, General and Administrative Excl. Other413.57380.64361.91409.01373.90430.54330.74191.18
Other Operating Expense0.000.000.000.000.000.000.000.00
Operating Income107.1625.71-30.46-187.35-206.08-283.1715.4415.24
Interest Expense9.7911.6626.5421.228.8324.5122.135.41
Unusual Expense6.362.711.8548.9418.4523.9637.441.96
Net Income Before Taxes89.8212.36-57.61-206.58-232.73-333.11-44.417.88
Income Taxes17.912.70-0.17-20.32-17.17-25.91-6.342.21
Consolidated Net Income71.919.66-57.44-186.26-215.56-307.20-38.075.67
Net Income From Continuing Operations71.919.66-57.44-186.26-215.56-307.20-38.075.67
Net Income71.919.66-57.44-186.26-215.56-343.95-311.31-58.90
EPS (Recurring)0.200.03-0.15-0.41-0.57-1.00-0.76-0.15
EPS (Basic, Before Extraordinaries)0.190.03-0.15-0.51-0.61-1.05-0.83-0.16
EPS (Diluted)0.180.02-0.15-0.51-0.61-1.05-0.83-0.16
EBITDA163.1080.4640.49-106.91-136.88-229.0346.4821.34
Non-Operating Income (Expense)-1.191.031.2350.920.63-1.47-0.280.00
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense55.1659.0160.1878.52148.07189.391.060.04
Price To Earnings Ratio78.9278.92------
Price To Sales Ratio2.811.932.232.732.044.67--
Gross Margin31.0528.5326.5021.0019.5222.08--
Operating Margin6.391.80-2.43-17.75-23.98-42.424.097.17
Net Margin4.290.68-4.59-17.64-25.08-51.53-82.53-27.72
Shares Outstanding380.19388.32382.74378.73375.96374.25373.65373.65
Market Capitalization5,535.585,535.582,820.062,964.491,857.373,561.903,591.83-

Income statement, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q22025Q12024Q4
Total Revenue455.86435.35403.48382.19363.81345.31332.97325.48
Cost of Goods Sold Incl. D&A309.40296.56280.86269.33260.78250.89236.94230.72
Gross Profit146.47138.79122.61112.86103.0394.4296.0394.77
Selling, General and Administrative Excl. Other111.67107.24100.2494.4195.0496.7994.2093.77
Other Operating Expense0.000.000.000.000.000.000.000.00
Operating Income34.7931.5522.3718.457.98-2.361.831.00
Interest Expense2.492.631.792.882.812.903.079.40
Unusual Expense4.601.44-0.110.430.501.540.430.73
Net Income Before Taxes27.4027.4619.7615.204.57-5.94-1.47-8.88
Income Taxes5.023.855.523.543.50-2.15-2.18-1.76
Consolidated Net Income22.3923.6114.2411.671.08-3.790.71-7.11
Net Income From Continuing Operations22.3923.6114.2411.671.08-3.790.71-7.11
Net Income22.3923.6114.2411.671.08-3.790.71-7.11
EPS (Recurring)0.070.060.040.030.00-0.010.00-0.02
EPS (Basic, Before Extraordinaries)0.060.060.040.030.00-0.010.00-0.02
EPS (Diluted)0.060.060.040.030.00-0.010.00-0.02
EBITDA49.7345.8035.6931.8821.5411.6415.5915.67
Non-Operating Income (Expense)-0.30-0.02-0.920.06-0.090.860.200.26
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense14.3515.6012.0113.2014.4516.6814.6812.76
Price To Earnings Ratio78.92180.91254.80-----
Price To Sales Ratio2.812.621.681.921.561.522.032.25
Gross Margin32.1331.8830.3929.5328.3227.3428.8429.12
Operating Margin7.637.255.544.832.19-0.680.550.31
Net Margin4.915.423.533.050.30-1.100.21-2.19
Shares Outstanding380.19382.02387.81388.32389.00389.08388.83382.74
Market Capitalization5,535.584,153.702,482.922,738.562,139.152,010.492,561.102,820.06

Balance sheet, annual

Currency USD, millions
Metric2025FY2024FY2023FY2022FY2021FY2020FY2019FY
Cash & Short Term Investments248.64154.5778.82108.62148.0318.833.48
Short Term Receivables99.50132.03125.64106.1599.3151.5221.03
Inventories0.000.000.000.000.000.000.00
Other Current Assets68.0625.9121.2718.4519.185.932.91
Total Current Assets416.20312.51225.73233.22266.5276.2827.43
Net Property, Plant & Equipment311.30313.92358.93393.62152.2459.3522.43
Total Investments and Advances0.000.000.000.000.000.000.00
Intangible Assets1,471.011,484.141,514.421,536.231,504.901,431.45229.56
Deferred Tax Assets112.59108.74123.24117.0542.5610.852.16
Other Assets5.427.7210.8910.793.452.651.36
Total Assets2,316.532,227.042,233.212,290.921,969.661,580.58282.94
Short Term Debt Incl. Current Port. of LT Debt60.0456.7049.4041.171.323.740.84
Accounts Payable6.127.247.0512.2914.157.693.64
Income Tax Payable-----0.450.19
Other Current Liabilities185.80164.94146.42122.55101.2864.0550.33
Total Current Liabilities251.96228.89202.87176.00116.7575.9255.01
Long Term Debt414.48428.49461.64437.67157.42362.5379.31
Provision for Risks Charges0.000.000.000.000.000.000.00
Deferred Tax Liabilities129.00123.07138.81155.7596.8492.083.02
Other Liabilities0.070.310.952.7853.6317.219.04
Total Liabilities795.51780.75804.28772.19424.64547.74146.38
Non-Equity Reserves0.000.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.0035.00302.91
Common Equity1,521.021,446.291,428.931,518.721,545.03997.84-166.35
Total Shareholders Equity1,521.021,446.291,428.931,518.721,545.031,032.84136.56
Accumulated Minority Interest0.000.000.000.000.000.000.00
Total Equity1,521.021,446.291,428.931,518.721,545.031,032.84136.56
Total Liabilities & Stockholders Equity2,316.532,227.042,233.212,290.921,969.661,580.58282.94
Book Value Per Share3.923.783.774.044.132.67-0.45
Tangible Book Value Per Share0.13-0.10-0.23-0.050.11-1.16-1.06
Full-Time Employees10,96110,2189,3257,8306,6354,4504,450
Price to Book Ratio3.711.962.041.212.312.33-
Return on Assets0.43-2.58-8.23-10.12-17.31-4.09-
Return on Equity0.65-4.00-12.64-14.07-23.83-6.51-
Return on Invested Capital0.50-3.06-9.85-11.02-18.04-2.732.63
Quick Ratio1.651.371.111.332.281.000.50
Current Ratio1.651.371.111.332.281.000.50

Cash flow, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY
Net Income71.919.66-57.44-186.26-215.56-307.20-38.075.67
Depreciation55.9454.7570.9580.4469.2054.1431.056.09
Other Funds (Non Cash)119.12119.66122.08144.58232.83287.295.750.53
Funds from Operations249.38186.50134.6316.8469.737.28-7.7814.06
Extraordinary Item0.000.000.000.000.000.000.000.00
Changes in Working Capital-21.79-40.34-27.37-33.72-16.942.14-0.752.99
Cash from Operating Activities227.60146.15107.26-16.8852.799.42-8.5317.05
Capital Expenditures-48.33-36.12-21.57-40.52-79.25-94.49-38.07-14.31
Net Assets From Acquisitions-9.590.000.00-19.82-60.21-99.58-823.10-59.06
Sale of Fixed Assets and Businesses0.000.000.000.000.000.000.000.00
Purchase or Sale of Investments0.000.000.000.000.000.000.000.00
Purchase of Investments0.000.000.000.000.000.000.000.00
Sale Or Maturity of Investments0.000.000.000.000.000.000.000.00
Other Uses0.000.000.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.000.000.00
Cash from Investing Activities-57.92-36.12-21.57-60.34-139.46-194.08-861.17-73.38
Cash Dividends Paid0.000.000.000.000.000.000.000.00
Change in Capital Stock-117.060.000.000.000.00549.9020.000.00
Repurchase of Common Pref Stock-122.430.000.000.000.000.00-1.000.00
Sale of Common Pref Stock5.370.000.000.000.00549.9021.000.00
Proceedsfrom Stock Options0.000.000.000.000.00549.9021.000.00
Issuance or Reduction of Debt, Net-12.69-7.25-3.5055.0960.68-223.77282.0753.49
Change in Long Term Debt-12.69-7.25-3.5055.0960.68-223.77282.0753.49
Issuance of Long Term Debt0.000.00285.9957.56250.0696.44457.0853.97
Reduction of Long Term Debt-12.69-7.25-289.49-2.47-189.38-320.21-175.01-0.49
Net Financing Active Other Cash Flow-25.02-8.71-6.44-7.67-13.42-12.28610.20-5.02
Other Financing Activities Uses-25.02-8.71-6.44-7.67-13.42-12.28-23.38-5.02
Cash from Financing Activities-154.77-15.96-9.9547.4347.26313.86912.2748.46
Net Change in Cash14.9194.0775.75-29.80-39.41129.2042.57-7.86
Free Cash Flow179.27110.0385.69-57.40-26.47-85.07-46.602.73
Preferred Dividends (Cash Flow)-0.000.000.000.00---
Price to Free Cash Flow26.2525.0332.61-----
Deferred Taxes & Investment Tax Credit-2.42-0.96-21.92-16.73-26.95-6.501.76

Balance sheet, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Cash & Short Term Investments218.82225.94194.80248.64203.90188.93
Short Term Receivables120.94110.96122.9299.50121.07129.48
Inventories0.000.000.000.000.000.00
Other Current Assets37.0241.0638.2068.0635.4040.44
Total Current Assets376.78377.97355.91416.20360.38358.85
Net Property, Plant & Equipment328.82321.70312.99311.30308.38303.76
Total Investments and Advances0.000.000.000.000.000.00
Intangible Assets1,475.431,477.361,472.141,471.011,474.101,477.31
Deferred Tax Assets---112.59--
Other Assets5.254.474.845.426.126.88
Total Assets2,186.282,181.502,145.882,316.532,148.972,146.80
Short Term Debt Incl. Current Port. of LT Debt59.5461.0065.4960.0460.0657.96
Accounts Payable5.5011.054.296.1212.217.79
Other Current Liabilities196.09202.70169.95185.80156.28176.53
Total Current Liabilities261.13274.75239.73251.96228.56242.28
Long Term Debt415.98413.15411.28414.48413.58416.29
Provision for Risks Charges0.000.000.000.000.000.00
Deferred Tax Liabilities16.4116.4116.41129.0013.9914.13
Other Liabilities0.370.041.050.070.100.18
Total Liabilities693.89704.35668.47795.51656.23672.88
Non-Equity Reserves0.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.00
Common Equity1,492.391,477.151,477.421,521.021,492.741,473.92
Total Shareholders Equity1,492.391,477.151,477.421,521.021,492.741,473.92
Accumulated Minority Interest0.000.000.000.000.000.00
Total Equity1,492.391,477.151,477.421,521.021,492.741,473.92
Total Liabilities & Stockholders Equity2,186.282,181.502,145.882,316.532,148.972,146.80
Book Value Per Share3.933.873.813.923.843.79
Tangible Book Value Per Share0.04-0.000.010.130.05-0.01
Full-Time Employees---10,961--
Price to Book Ratio3.712.811.631.831.451.38
Return on Assets3.322.341.090.43-0.43-0.76
Return on Equity4.823.431.580.65-0.62-1.11
Return on Invested Capital1.171.250.750.600.06-0.20
Quick Ratio1.441.381.481.651.581.48
Current Ratio1.441.381.481.651.581.48

Cash flow, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Net Income22.3923.6114.2411.671.08-3.79
Depreciation14.9414.2513.3213.4313.5614.01
Other Funds (Non Cash)32.5332.1026.3028.1929.8432.20
Funds from Operations69.8569.9653.8655.7244.4742.42
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital-32.8329.95-20.751.84-17.1821.98
Cash from Operating Activities37.0299.9133.1157.5627.2964.40
Capital Expenditures-14.65-11.99-10.77-10.91-10.29-7.75
Net Assets From Acquisitions-0.55-5.89-3.140.000.000.00
Sale of Fixed Assets and Businesses0.000.000.000.000.000.00
Purchase or Sale of Investments0.000.000.000.000.000.00
Purchase of Investments0.000.000.000.000.000.00
Sale Or Maturity of Investments0.000.000.000.000.000.00
Other Uses0.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.00
Cash from Investing Activities-15.21-17.89-13.91-10.91-10.29-7.75
Cash Dividends Paid0.000.000.000.000.000.00
Preferred Dividends (Cash Flow)0.000.000.000.000.000.00
Change in Capital Stock-24.80-43.15-49.110.000.000.00
Repurchase of Common Pref Stock-24.80-48.52-49.110.000.000.00
Sale of Common Pref Stock0.005.370.000.000.000.00
Proceedsfrom Stock Options0.000.000.000.000.000.00
Issuance or Reduction of Debt, Net-3.62-7.250.00-1.81-1.81-1.81
Change in Long Term Debt-3.62-7.250.00-1.81-1.81-1.81
Issuance of Long Term Debt0.000.000.000.000.000.00
Reduction of Long Term Debt-3.62-7.250.00-1.81-1.81-1.81
Net Financing Active Other Cash Flow-0.51-0.48-23.94-0.10-0.21-0.24
Other Financing Activities Uses-0.51-0.48-23.94-0.10-0.21-0.24
Cash from Financing Activities-28.93-50.88-73.04-1.91-2.02-2.05
Net Change in Cash-7.1231.15-53.8444.7414.9754.59
Free Cash Flow22.3687.9222.3446.6517.0056.64
Price to Free Cash Flow26.2523.8517.6524.8517.9216.65

Revenue breakdown

Services-Health Services2024: 1.25B 2025: 1.42B
United States2024: 1.25B 2025: 1.42B

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-305.30%13.7M258.0M4.37M
2026-10-155.31%13.8M259.4M4.31M
2026-09-305.94%15.5M261.2M4.43M
2026-09-156.23%16.3M261.2M4.22M
2026-08-315.59%13.6M243.5M3.74M
2026-08-144.69%11.4M243.7M3.71M
2026-07-314.16%9.6M230.1M4.16M
2026-07-154.05%9.5M233.6M4.75M
2026-06-304.09%9.6M235.1M4.38M
2026-06-153.43%8.0M234.2M3.90M
2026-05-293.39%7.9M234.4M3.98M
2026-05-153.66%8.6M234.4M4.05M
2026-04-303.76%6.9M183.4M2.97M
2026-04-153.56%6.6M184.3M2.19M
2026-03-314.49%7.2M160.6M2.22M
2026-03-134.86%7.8M160.6M2.32M
2026-02-276.43%10.3M160.6M2.14M
2026-02-134.85%7.8M160.2M1.94M
2026-01-304.95%7.9M160.2M2.17M
2026-01-154.99%8.0M160.2M2.11M

Option chain

expiry 2026-11-20
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
call5.000.000.000.00-0.000.00---
call6.000.000.000.00-0.000.00---
call7.000.000.000.00-0.000.00---
call8.000.000.003.90-1.000.00---
call9.000.000.000.00-0.000.00---
call10.000.000.000.00-0.000.00---
call11.000.000.001.20-8.000.00---
call12.000.000.002.62-1070.00---
call13.000.000.001.58-1270.00---
call14.000.000.001.00-1790.00---
call15.000.000.000.25-6.000.00---
call16.000.000.000.05-5780.00---
call17.000.000.000.00-0.000.00---
call18.000.000.000.00-0.000.00---
call19.000.000.000.00-0.000.00---
call20.000.000.000.00-0.000.00---
call21.000.000.000.00-0.000.00---
put5.000.000.000.00-0.000.00---
put6.000.000.000.00-0.000.00---
put7.000.000.000.00-0.000.00---
put8.000.000.000.00-0.000.00---
put9.000.000.000.00-0.000.00---
put10.000.000.000.00-0.000.00---
put11.000.000.000.00-0.000.00---
put12.000.000.000.10-1090.00---
put13.000.000.000.63-5.000.00---
put14.000.000.000.70-90.000.00---
put15.000.000.000.70-2.000.00---
put16.000.000.000.00-0.000.00---
put17.000.000.000.00-0.000.00---
put18.000.000.000.00-0.000.00---
put19.000.000.000.00-0.000.00---
put20.000.000.000.00-0.000.00---
put21.000.000.000.00-0.000.00---

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-11-10144Filing for proposed sale of securities under Rule 144.SEC
2026-11-10144Filing for proposed sale of securities under Rule 144.SEC
2026-11-10144Filing for proposed sale of securities under Rule 144.SEC
2026-11-10424B7SEC
2026-11-09144Filing for proposed sale of securities under Rule 144.SEC
2026-11-09424B7SEC
2026-11-0510-QQuarterly report pursuant to Section 13 or 15(d)2026-09-30SEC
2026-11-058-KCurrent report2026-11-05SEC
2026-10-168-KCurrent report2026-10-14SEC
2026-10-05SCHEDULE 13G/ASEC
2026-09-244Statement of changes in beneficial ownership of securities2026-09-22SEC
2026-09-154Statement of changes in beneficial ownership of securities2026-09-11SEC
2026-09-118-KCurrent report2026-09-09SEC
2026-09-10424B7SEC
2026-09-09424B7SEC
2026-09-044Statement of changes in beneficial ownership of securities2026-09-02SEC
2026-09-044Statement of changes in beneficial ownership of securities2026-09-02SEC
2026-09-02144Filing for proposed sale of securities under Rule 144.SEC
2026-08-264Statement of changes in beneficial ownership of securities2026-08-24SEC
2026-08-184Statement of changes in beneficial ownership of securities2026-08-14SEC
2026-08-14SCHEDULE 13G/ASEC
2026-08-14144Filing for proposed sale of securities under Rule 144.SEC
2026-08-144Statement of changes in beneficial ownership of securities2026-08-13SEC
2026-08-13144Filing for proposed sale of securities under Rule 144.SEC
2026-08-134Statement of changes in beneficial ownership of securities2026-08-11SEC
2026-08-124Statement of changes in beneficial ownership of securities2026-08-10SEC
2026-08-124Statement of changes in beneficial ownership of securities2026-08-10SEC
2026-08-124Statement of changes in beneficial ownership of securities2026-08-10SEC
2026-08-11144Filing for proposed sale of securities under Rule 144.SEC
2026-08-11SCHEDULE 13G/ASEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-110000
2026-100000
2026-0900226.80M2
2026-0800151.99M6
2026-070000
2026-06009.06M1
2026-0500281.34M5
2026-0400528.16K3
2026-0300175.25M2
2026-020000
2026-010000
2025-12001.89M6
2025-1100368.05K1

Institutional holders

Manager% owned
TPG GP A, LLC28.81%
FMR LLC15.56%
BlackRock, Inc.9.37%
SUMMIT PARTNERS L P4.35%
VANGUARD PORTFOLIO MANAGEMENT LLC3.60%
JENNISON ASSOCIATES LLC3.11%
VANGUARD CAPITAL MANAGEMENT LLC2.51%
DIMENSIONAL FUND ADVISORS LP2.21%
STATE STREET CORP2.12%
GEODE CAPITAL MANAGEMENT, LLC1.82%

Funds

Fund% owned
iShares Core S&P Small-Cap ETF3.56%
VANGUARD TOTAL STOCK MARKET INDEX FUND1.74%
Fidelity Small Cap Value Fund1.68%
VIP Contrafund Portfolio1.53%
Fidelity Small Cap Growth Fund1.40%
Select Health Care Portfolio1.31%
iShares Russell 2000 ETF1.29%
VANGUARD SMALL-CAP INDEX FUND1.26%
PGIM Jennison Small Company Fund1.25%
Fidelity Value Fund1.17%

OakChart. LFST. Cached 15 minutes.